ArticleFrontiers in immunology2025

Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoimmune blistering dermatosis.

Björn Laffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.